at the last ''seronegative'' visit was retested to determine the preva- lence of early infection in these 267 participants.
Early (pre-seroconversion) infection with human immunodeficiency virus type 1 (HIV-1) was identified in 50 of 267 participants in the Multicenter AIDS Cohort Study. These 50 men had a positive EIA result, which detected IgM antibody (n Å 35), p24 antigen, or serum HIV RNA (n Å 15) at their last ''seronegative'' visit. At that visit, the mean CD4 lymphocyte number (890/mm 3 vs. 1038/mm 3 ) was significantly lower than in men who subsequently seroconverted but had no evidence of early infection. The decline in CD4 cells was slower and the duration of AIDS-free time longer in the 19 men who were symptomatic in comparison to the 31 asymptomatic men with early infection, but differences were not significant.
Identification and treatment of early infection due to human
sion by Ç1 week [8] . The use of techniques to detect viral p24 antigen and RNA in serum also decreases the time between immunodeficiency virus type 1 (HIV-1) has been advocated as a means of reducing viral replication and favorably altering establishment and diagnosis of infection with HIV-1 [9] [10] [11] . We used assays to identify persons with early HIV infection disease progression [1, 2] . As a significant number of persons with primary infection are asymptomatic [3] , it has been sugand sought to determine whether symptomatic primary infection was associated with clinical progression. gested that symptomatic incident HIV-1 infection is associated with more rapid immunologic deterioration and clinical progression [4] [5] [6] [7] . Methods The ''seronegative'' phase of primary infection generally lasts between 2 and 6 weeks [3] . Recently, an EIA capable of Details of the Multicenter AIDS Cohort Study (MACS), a prodetecting IgM as well as IgG antibody has been shown to spective investigation of the natural history of HIV-1 infection reduce the window period between inoculation and seroconveramong homosexual and bisexual men, have been published [12] . The participants included in this analysis were the 267 men with incident infection occurring within an interval of õ7 months (median, 6; range, 4-7) between the last seronegative and first seropositive visit identified using first-generation EIAs. Serum obtained tions were added to ascertain if symptoms of 3 days' duration had been present during the intervisit interval. Reports of symptoms lasting at least 3 days were recorded for 151 (56.6%) of these 267 men. The presence or absence of generalized lymphadenopathy was identified on the physical examination at the last seronegative visit, and data were available for 266 men. Lymphadenopathy was defined as enlargement of lymph nodes in two or more chains, excluding inguinal nodes.
T cell phenotyping at each visit was performed with standard flow cytometry and blood counting methods previously described [13] . Figure 1 . Serologic and virologic determination of infection at last Sera obtained at the last seronegative visit from 227 men in this seronegative visit (by indirect EIA) for 50 participants who subsestudy were retested using a direct EIA for IgG and IgM HIV-1-quently seroconverted. PCR, polymerase chain reaction. specific antibody (Abbott, North Chicago, IL), an assay for p24 antigen based on a monoclonal antibody sandwich EIA (Abbott), and a polymerase chain reaction (PCR)-based assay for HIV RNA of these 37 sera had a positive WB, with two or more positive [8] [9] [10] [11] . Forty sera were tested for p24 antigen and HIV RNA bands: p24, gp41, or gp120/160. Of the remaining 27, 10 were frequent complaints were fatigue (20.0%), rash (18.0%), nodal
Kaplan-Meier survival estimates were used to ascertain the time enlargement or tenderness (18.3%), and night sweats (13.3%).
to AIDS by group. Men without a diagnostic event were considered Only 9.2% of the men reported fever. Among the men with alive without AIDS if they were contacted as of 1 July 1994, that evidence of early infection, fatigue, rash, nodal enlargement, is, 1 year prior to the date of analysis. Otherwise, a subject was fever, and night sweats were noted for 3 days by 38.1%, 26.3%, censored at the time of last contact or at the date of death. Log-rank 55.0%, 40.0%, and 36.4%, respectively. Fourteen of these 19 statistics were used to determine whether there were significant had two or more symptoms. Overall, 19 (38%) of 50 men with differences in AIDS-free survival. Since the hazard functions were not proportional, we did not use multivariate proportional hazard early infection and 58 (27%) of 217 men with no evidence of models; subgroup differences were assessed using stratification.
infection at the last seronegative visit reported at least one symptom persisting for 3 days or 2 weeks (P Å .11). Eight (16.0%) of the 50 with primary infection and 39 (18.1%) of Results the 216 participants without evidence of infection at that visit had lymphadenopathy. Fifty of the 267 seroconverters were identified as infected at the last seronegative visit (figure 1). Thirty-seven (16.3%)
The mean CD4 lymphocyte count was significantly (P Å .03) lower among the 50 infected men (890 { 437.6/mm 3 ) than of 227 sera assayed for IgM and IgG antibody, but negative for antibody using a first-generation EIA, were reactive. To among the 217 seroconverters without evidence of infection (1038 { 435.4/mm 3 ) at the last ''seronegative'' visit. The mean confirm HIV infection, sera were sequentially assayed by WB, sandwich EIA for p24 antigen, and PCR for HIV RNA. Ten CD4 cell number for these 217 men did not differ significantly (P Å .42) from the mean value of the CD4 lymphocyte number not developed serologic evidence of an immune response at this visit. for the persistently uninfected cohort in the MACS (1008 { 388.6/mm 3 ). The mean CD8 lymphocyte numbers at the last If infection occurred uniformly across the intervisit interval seronegative visit were not significantly (P Å .3) different be-(median, 6 months), one-sixth of the participants with incident tween the seroconverting groups.
infection would have been expected to be in the 2-to 6-week Following the estimated date of seroconversion, defined as ''pre-seroconversion'' window and have evidence of infection the midpoint between the last seronegative and first seropositive at their last ''seronegative'' visit. The proportion (18.7%) of visits, the mean follow-up time to AIDS or date of analysis (1 participants in this study with laboratory evidence of infection July 1995) among the 267 seroconverters was 8.5 years. The at this visit is consistent with this postulate. These results illusmean CD4 cell count slope ({SE) for the 19 infected symptomtrate that assays sensitive for the presence of antibody and virus atic men was 056.5 { 128.1/mm 3 and for the 31 infected can identify persons with early HIV-1 infection. asymptomatic men was 071.1 { 119.5/mm 3 (P ú .5). Men A greater proportion of participants with evidence of primary with symptomatic primary infection tended to progress to AIDS infection than of those without such findings reported sympmore slowly than asymptomatic infected men during the foltoms persisting for 3 days; however, data were available for low-up period (figure 2), but the difference was not significant only a limited number (56.6%) of the men. Lymphadenopathy (P Å .07). Participants with two or more symptoms also were was uncommon in participants both with and without laboratory free of AIDS for longer than the remaining 36 men with prievidence of primary infection. However, utilization of selfmary infection who were asymptomatic or who had only one reported symptoms or presence of lymphadenopathy or both symptom.
to identify persons with early HIV-1 infection in this study would have falsely excluded a large number of men with incident infection. Strategies to identify persons with early HIV-1 infection will require periodic laboratory testing of highDiscussion risk persons in addition to a screening history and physical examination. Fifty men with incident HIV-1 infection in the MACS had Studies of early infection from the MACS, Amsterdam, and laboratory evidence of early HIV-1 infection at their last ''seroVancouver cohorts avoid selection and diagnostic biases potennegative'' visit. Thirty-five men were seropositive when tested tially present in investigations dependent on referral of patients using a direct EIA that detects IgM and IgG HIV-specific from clinical practices. In the other cohort studies, symptomatic antibody, and infection was confirmed by a positive WB, a primary HIV-1 infection has been reported to be associated p24 antigen assay, or assay of serum for HIV RNA. The remaining 15 subjects were positive for virus markers but had with more rapid progression [4, 5] , but this association could
